These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21782770)

  • 41. Systematic review: duodenogastroesophageal (biliary) reflux prevalence, symptoms, oesophageal lesions and treatment.
    Basnayake C; Geeraerts A; Pauwels A; Koek G; Vaezi M; Vanuytsel T; Tack J
    Aliment Pharmacol Ther; 2021 Sep; 54(6):755-778. PubMed ID: 34313333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement?
    Chey WD; Mody RR; Izat E
    Dig Dis Sci; 2010 Dec; 55(12):3415-22. PubMed ID: 20397047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France.
    Bruley des Varannes S; Löfman HG; Karlsson M; Wahlqvist P; Ruth M; Furstnau ML; Despiégel N; Stålhammar NO
    BMC Gastroenterol; 2013 Feb; 13():39. PubMed ID: 23448382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.
    Becher A; El-Serag H
    Aliment Pharmacol Ther; 2011 Sep; 34(6):618-27. PubMed ID: 21770991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient- and physician-reported satisfaction with gastroesophageal reflux disease (GERD) treatment in Chinese clinical practice.
    Xiao YL; Zhang MY; Tan ND; Chen SF; Zhuang QJ; Chen MH
    J Dig Dis; 2022 May; 23(5-6):262-269. PubMed ID: 35734857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies.
    El-Serag H; Becher A; Jones R
    Aliment Pharmacol Ther; 2010 Sep; 32(6):720-37. PubMed ID: 20662774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms.
    Delshad SD; Almario CV; Chey WD; Spiegel BMR
    Gastroenterology; 2020 Apr; 158(5):1250-1261.e2. PubMed ID: 31866243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
    Fujiwara Y; Habu Y; Ashida K; Kusano M; Higuchi K; Arakawa T
    Digestion; 2013; 88(3):145-52. PubMed ID: 24008338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)?
    Spechler SJ
    Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
    Kahrilas PJ; Howden CW; Hughes N
    Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. National Study of Off-label Proton Pump Inhibitor Use Among New Zealand Infants in the First Year of Life (2005-2012).
    Blank ML; Parkin L
    J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):179-184. PubMed ID: 28403034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does treatment with proton pump inhibitors for gastroesophageal reflux disease (GERD) improve asthma symptoms in children with asthma and GERD? A systematic review.
    Sopo SM; Radzik D; Calvani M
    J Investig Allergol Clin Immunol; 2009; 19(1):1-5. PubMed ID: 19274922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms.
    Nakada K; Matsuhashi N; Iwakiri K; Oshio A; Joh T; Higuchi K; Haruma K
    World J Gastroenterol; 2017 Jul; 23(28):5216-5228. PubMed ID: 28811716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease.
    Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N
    Korean J Gastroenterol; 2016 Jul; 68(1):10-5. PubMed ID: 27443618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proton pump inhibitor-refractory gastroesophageal reflux disease: current diagnosis and management.
    Frazzoni L; Fuccio L; Frazzoni M
    Minerva Gastroenterol Dietol; 2017 Sep; 63(3):249-256. PubMed ID: 28251845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing the impact of lifestyle modification education on knowledge and behavior changes in gastroesophageal reflux disease patients on proton pump inhibitors.
    Finley K; Giannamore M; Bennett M; Hall L
    J Am Pharm Assoc (2003); 2009; 49(4):544-8. PubMed ID: 19589767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
    Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
    Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perspectives on gastroesophageal reflux disease in primary care: the REFLEX study of patient-physician agreement.
    Dorval E; Rey JF; Soufflet C; Halling K; Barthélemy P
    BMC Gastroenterol; 2011 Mar; 11():25. PubMed ID: 21435198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.
    Lin BM; Curhan SG; Wang M; Jacobson BC; Eavey R; Stankovic KM; Curhan GC
    Ear Hear; 2017; 38(1):21-27. PubMed ID: 27556519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.